168766-16-3

Usage

Uses

Used in Pharmaceutical Industry:
Benzeneethanol, 2,6-difluoro(9CI) is employed as a solvent in the pharmaceutical industry for the production of various medications. Its ability to dissolve a wide range of substances makes it a valuable component in the formulation of drugs.
Used in Pesticide Industry:
In the pesticide industry, Benzeneethanol, 2,6-difluoro- (9CI) is used as a solvent in the manufacturing process of different types of pesticides. Its properties allow for the effective incorporation of active ingredients, enhancing the performance of these agricultural chemicals.
Used in Chemical Synthesis:
Benzeneethanol, 2,6-difluoro(9CI) is utilized as an intermediate in the synthesis of other complex organic compounds. Its role in chemical reactions is crucial for the production of a variety of specialty chemicals used across different industries.
Used in Manufacturing Processes:
Benzeneethanol, 2,6-difluoro(9CI) is also used in various manufacturing processes due to its solvent capabilities. It aids in the production of a range of products by facilitating the mixing and reaction of different substances.

Upstream product

• 85068-28-6 2,6-difluorophenylacetic acid 
• 680217-71-4 (2,6-difluorophenyl)acetic acid ethyl ester 
• 872046-08-7 (2,6-difluorophenyl)acetic acid methyl ester 

Downstream Products

• 1309752-62-2 2-(2,6-difluoro-3-nitrophenyl)ethyl acetate 
• 1309752-63-3 2-[2-({2-[(tert-butoxycarbonyl)amino]ethyl}amino)-6-fluoro-3-nitrophenyl]ethyl acetate 
• 1309752-66-6 tert-butyl [2-(2-phenyl-7,8-dihydro-1H-furo[3,2-e]benzimidazol-1-yl)ethyl]carbamate 
• 1309752-69-9 N-[2-(2-phenyl-7,8-dihydro-1H-furo[3,2-e]benzimidazol-1-yl)ethyl]acetamide 
• 1309752-61-1 2-(2,6-difluorophenyl)ethyl acetate 
• 1354199-03-3 2-(2,6-difluorophenethyl)-6-(4-(trifluoromethoxy)phenyl)-[1,2,4]triazolo[4,3-a]pyridin-3(2H)-one 
• 872046-07-6 methanesulfonic acid 2-(2,6-difluoro-phenyl)-ethyl ester 

Relevant academic research and scientific papers

TRIAZOLOPYRIDINE ETHER DERIVATIVES AND THEIR USE IN NEUROLOGICAL AND PYSCHIATRIC DISORDERS

The disclosure generally relates to compounds of formula I, including their salts, as well as compositions and methods of using the compounds. The compounds modulate the mGluR2 receptor and may be useful for the treatment of various disorders of the central nervous system.

Synthesis of a novel series of tricyclic dihydrofuran derivatives: Discovery of 8,9-dihydrofuro[3,2-c ]pyrazolo[1,5-a ]pyridines as melatonin receptor (MT1/MT2) ligands

Novel tricyclic dihydrofuran derivatives were designed, synthesized, and evaluated as melatonin receptor (MT1/MT2) ligands based on the previously reported 1,6-dihydro-2H-indeno[5,4-b]furan 1a. By screening the central tricyclic cores, we identified 8,9-dihydrofuro[3,2-c]pyrazolo[1,5-a] pyridine as a potent scaffold with a high ligand-lipophilicity efficiency (LLE) value. Subsequent optimization of the side chains led to identification of the potent MT1/MT2 agonist 4d (MT1, Ki = 0.062 nM; MT2, Ki = 0.420 nM) with good oral absorption and blood-brain barrier (BBB) penetration in rats. The oral administration of compound 4d exhibited a sleep-promoting action in freely moving cats at 0.1 mg/kg.

NEW OXABISPIDINE COMPOUNDS FOR THE TREATMENT OF CARDIAC ARRHYTHMIAS

There is provided compounds of formula I, [Chemical formula should be inserted here. Please see paper copy] wherein R1 to R4 , R41 to R46 and Z have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias

NOVEL OXABISPIDINE COMPOUNDS AND THEIR USE IN THE TREATMENT OF CARDIAC ARRHYTHMIAS

There is provided compounds of formula (I), wherein R1, R2, R3, R4, R 41 to R46, A, B and G have meanings given in the description, which are useful in the prophylaxis and in the treatment of arrhythmias, in particular atrial and ventricular arrhythmias.